Paper
Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging.
Published Nov 28, 2013 · A. Seynhaeve, B. Dicheva, S. Hoving
Journal of controlled release : official journal of the Controlled Release Society
135
Citations
5
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Doxil, a liposomal doxorubicin formulation, is taken up by tumor cells and slowly degraded, making it less effective in killing tumor cells compared to free doxorubicin.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...